Document Detail

Advances in the treatments of systemic vasculitides.
MedLine Citation:
PMID:  18181034     Owner:  NLM     Status:  MEDLINE    
Necrotizing systemic vasculitides are severe diseases in which prognosis improved since steroids and cytotoxic agents have been prescribed. The outcome is now better, and remission is obtained in more than 80% of patients. In this review paper, we will cover the indications of conventional treatments and new biotherapies and other therapies. The strategies that improve patient's outcome are discussed in the light of the prospective trials organized by international research groups.
Loïc Guillevin
Related Documents :
17209164 - Sciatica: treatment with intradiscal and intraforaminal injections of steroid and oxyge...
22782694 - Mrsa decolonization: success rate, risk factors for failure and optimal duration of fol...
23839704 - Outcomes in severe middle cerebral artery ischemic stroke.
1568574 - Endoscopic monitoring of crohn's disease treatment: a prospective, randomized clinical ...
1717094 - Strontium-89 chloride for pain palliation in prostatic skeletal malignancy.
16607564 - High tibial osteotomy with puddu plate for the treatment of varus gonarthrosis.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical reviews in allergy & immunology     Volume:  35     ISSN:  1080-0549     ISO Abbreviation:  Clin Rev Allergy Immunol     Publication Date:  2008 Oct 
Date Detail:
Created Date:  2008-09-02     Completed Date:  2008-11-04     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9504368     Medline TA:  Clin Rev Allergy Immunol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  72-8     Citation Subset:  IM    
Service de Médecine Interne, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Université Paris René Descartes, 27 rue du Faubourg Saint-Jacques, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenal Cortex Hormones / therapeutic use
Antibodies, Monoclonal / therapeutic use
Churg-Strauss Syndrome / therapy
Cryoglobulinemia / therapy
Cyclophosphamide / therapeutic use
Hepatitis B / complications
Immunoglobulins, Intravenous / therapeutic use
Plasma Exchange
Vasculitis / classification,  therapy*
Reg. No./Substance:
0/Adrenal Cortex Hormones; 0/Antibodies, Monoclonal; 0/Immunoglobulins, Intravenous; 50-18-0/Cyclophosphamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Targeted biologic approaches to the treatment of systemic vasculitis.
Next Document:  Pathways to ANCA production: from differentiation of dendritic cells by proteinase 3 to B lymphocyte...